Clinical Trials Browser

Lymphoma × Infusions, Intravenous × Clear all

NCT04477772 2024-05-16

A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China

Phase 1 Completed

Lymphoma